IMP - Research Institute of Molecular Pathology
Add to Favorites Newsroom RSS Share
1030 Vienna, Austria

Our News on Newswise

Glycosylation: Mapping Uncharted Territory

Glycosylation is the most abundant protein modification - over half of the proteins in our cells are ‘decorated’ with glycans. These sugar structures alter protein activities in all organisms – from bacteria to human - influencing fundamental...
19-Sep-2017 10:05 AM EDT Add to Favorites

Ricin Only Lethal in Combination with Sugar

Researchers at the Austrian Academy of Sciences’ Institute for Molecular Biotechnology (IMBA) have discovered a means of immunising cells against the biological weapon ricin, as reported in the current issue of Cell Research.
18-Sep-2017 8:05 AM EDT Add to Favorites

Chromosome Mechanics Guide Nuclear Assembly

How a protein BAF crosslinks the DNA to allow proper nuclear envelope reformation
23-Aug-2017 5:05 AM EDT Add to Favorites

How Cells Hack Their Own Genes

Researchers at IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences - unveil novel mechanism for gene expression.
22-Aug-2017 4:05 AM EDT Add to Favorites

Splitting Cells: How a Dynamic Protein Machinery Executes ‘the Final Cut’

Every day billions of cells die in our body and need to be replaced by newly dividing cells. Cell division is a beautifully orchestrated process that involves multiple critical steps. At the very end, “cellular abscission” splits the membrane...
9-Jun-2017 4:05 AM EDT Add to Favorites

Building Better Brains: A Bioengineered Upgrade for Organoids

Scientists for the first time combine organoids with bioengineering. Using small microfilaments, they show improved tissue architecture that mimics human brain development more accurately and allows more targeted studies of brain development and its...
31-May-2017 3:05 AM EDT Add to Favorites

Connecting Brain Regions in a Dish – a New Organoid Technology to Detect Malfunctions in the Brain

Scientists at IMBA (Institute of Molecular Biotechnology) describe novel organoid technology combining various brain regions for investigation of epilepsy, and other neurological diseases, as reported in the current issue of Nature Methods.
10-May-2017 8:30 AM EDT Add to Favorites

Manuel Zimmer Selected HHMI-Wellcome International Research Scholar

Neuroscientist Manuel Zimmer, a group leader at the Research Institute of Molecular Pathology (IMP) in Vienna, has been selected as HHMI-Wellcome International Research Scholar. His work on C. elegans worms aims to uncover how the brain processes...
10-May-2017 7:05 AM EDT Add to Favorites

Our Experts on Newswise

Scientists Initiate First Ethical Guidelines for Organs Cultivated in Vitro

In the latest edition of the journal “Science”, Jürgen Knoblich, a leading authority on stem cells and deputy director of the IMBA (Institute for Molecular Biotechnology of the Austrian Academy of Sciences), together with international experts,...
18-Jan-2017 3:05 AM EST

Our YouTube Videos





Chat now!